Original Research
Published on 25 Nov 2013
A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2013.00288
- 5,830 views
- 9 citations
